ALDH1A1 and ovarian carcinoma: This was the case when two separate labs knocked down ALDH1A1 with shRNA in ovarian cancer cell lines[294] or patient-derived ovarian cancer spheroids[295], showing that ALDH1A1 decreases[294] and increases[295] proliferation.